Related references
Note: Only part of the references are listed.Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
Jingang Huang et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
UPDATE OF EULAR RECOMMENDATIONS FOR THE TREATMENT OF SYSTEMIC SCLEROSIS
O. Kowal-Bielecka et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies
Clara Dees et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Phototherapy, photodynamic therapy and photophoresis in the treatment of connective-tissue diseases: a review
E. A. Gordon Spratt et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with paediatric- or adult-onset disease
J. S. Mertens et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
SYSTEMIC SCLEROSIS IN 2014 Advances in cohort enrichment shape future of trial design
Yannick Allanore et al.
NATURE REVIEWS RHEUMATOLOGY (2015)
Eosinophilic fasciitis: Typical abnormalities, variants and differential diagnosis of fasciae abnormalities using MR imaging
T. Kirchgesner et al.
DIAGNOSTIC AND INTERVENTIONAL IMAGING (2015)
Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling
Christian Beyer et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis
Britta Maurer et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Blockade of IL-6 Trans Signaling Attenuates Pulmonary Fibrosis
Thanh-Thuy T. Le et al.
JOURNAL OF IMMUNOLOGY (2014)
Recurrence of morphea after successful ultraviolet A1 phototherapy: A cohort study
Rebecca Vasquez et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mortality and survival in systemic sclerosis: Systematic review and meta-analysis
Manuel Rubio-Rivas et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis
Lucille Desallais et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Personalized Medicine in Systemic Sclerosis: Facts and Promises
Rucsandra Dobrota et al.
CURRENT RHEUMATOLOGY REPORTS (2014)
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
Frank van den Hoogen et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Preclinical and translational research to discover potentially effective antifibrotic therapies in systemic sclerosis
Suzana Jordan et al.
CURRENT OPINION IN RHEUMATOLOGY (2013)
Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis
Angelo De Lauretis et al.
JOURNAL OF RHEUMATOLOGY (2013)
Riociguat for the Treatment of Pulmonary Arterial Hypertension
Hossein-Ardeschir Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis
J. D. Pauling et al.
PLATELETS (2013)
Therapeutic Inhibition of Tyrosine Kinases in Systemic Sclerosis: A Review of Published Experience on the First 108 Patients Treated with Imatinib
Vasiliki-Kalliopi Bournia et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2013)
The Fra-2 transgenic mouse model of systemic sclerosis
Britta Maurer et al.
VASCULAR PHARMACOLOGY (2013)
Blockade of Interleukin-6 Receptor Alleviates Disease in Mouse Model of Scleroderma
Shun Kitaba et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
Christian Beyer et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis
Korsa Khan et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
IL-6 Blockade Attenuates the Development of Murine Sclerodermatous Chronic Graft-Versus-Host Disease
Doanh Le Huu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Methotrexate Treatment in Juvenile Localized Scleroderma A Randomized, Double-Blind, Placebo-Controlled Trial
Francesco Zulian et al.
ARTHRITIS AND RHEUMATISM (2011)
Topical Imiquimod 5% Cream for Pediatric Plaque Morphea: A Prospective, Multiple-Baseline, Open-Label Pilot Study
Elena Pope et al.
DERMATOLOGY (2011)
Platelet-derived serotonin links vascular disease and tissue fibrosis
Clara Dees et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
A systematic review of morphea treatments and therapeutic algorithm
Brittany A. Zwischenberger et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Update on morphea Part II. Outcome measures and treatment
Nicole Fett et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Interleukin-6 Contributes to Inflammation and Remodeling in a Model of Adenosine Mediated Lung Injury
Mesias Pedroza et al.
PLOS ONE (2011)
Tyrosine Kinase Inhibitors in the Treatment of Systemic Sclerosis: From Animal Models to Clinical Trials
Naoki Iwamoto et al.
CURRENT RHEUMATOLOGY REPORTS (2011)
Imatinib Treatment for Idiopathic Pulmonary Fibrosis Randomized Placebo-controlled Trial Results
Craig E. Daniels et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
Anthony J. Tyndall et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Animal Models of Systemic Sclerosis Prospects and Limitations
Christian Beyer et al.
ARTHRITIS AND RHEUMATISM (2010)
Efficacy of Topical Tacrolimus 0.1% in Active Plaque Morphea Randomized, Double-Blind, Emollient-Controlled Pilot Study
Elisabeth B. M. Kroft et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2009)
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)
O. Kowal-Bielecka et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Extracorporeal Photochemotherapy for Generalized Deep Morphea
Jason H. Neustadter et al.
ARCHIVES OF DERMATOLOGY (2009)
Distinct Autoimmune Syndromes in Morphea
Justin J. Leitenberger et al.
ARCHIVES OF DERMATOLOGY (2009)
Pressure-independent effects of pharmacological stimulation of soluble guanylate cyclase on fibrosis in pressure-overloaded rat heart
Hiroyuki Masuyama et al.
HYPERTENSION RESEARCH (2009)
Mechanisms of Disease: Scleroderma.
Armando Gabrielli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
MRI findings in deep and generalized morphea (localized scleroderma)
Marius Horger et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2008)
Src kinases in systemic sclerosis
Catherine Skhirtladze et al.
ARTHRITIS AND RHEUMATISM (2008)
Linear morphoea follows Blaschko's lines
L. Weibel et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
BIBF 1120: Triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy
Frank Hilberg et al.
CANCER RESEARCH (2008)
Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice
A. Fabre et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
The Effect of Terguride in Carbon Tetrachloride-Induced Liver Fibrosis in Rat
Oyvind Hauso et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
Topical tacrolimus 0.1% ointment in the treatment of localized scleroderma. An open label clinical and histological study
Christina Stefanaki et al.
JOURNAL OF DERMATOLOGY (2008)
Successful therapy of a patient with therapy recalcitrant generalized bullous scleroderma by extracorporeal photopheresis and mycophenolate mofetil
M. Schlaak et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
Morphoea:: a manifestation of infection with Borrelia species?
K. Eisendle et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
En coup de sabre morphea and Parry-Romberg syndrome:: A retrospective review of 54 patients
Megha M. Tollefson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children
L. Weibel et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Juvenile localized scleroderma:: clinical and epidemiological features in 750 children.: An international study
F Zulian et al.
RHEUMATOLOGY (2006)
A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma
A Kreuter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma
A Kreuter et al.
ARCHIVES OF DERMATOLOGY (2005)
Localized scleroderma: response to occlusive treatment with tacrotimus ointment
G Mancuso et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Scleroderma in children and adolescents
KJ Murray et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2002)
NO-independent regulatory site on soluble guanylate cyclase
JP Stasch et al.
NATURE (2001)
Methotrexate and corticosteroid therapy for pediatric localized scleroderma
Y Uziel et al.
JOURNAL OF PEDIATRICS (2000)
Share Paper
